SCM
OACCW

Shaolin Capital Management’s Oaktree Acquisition Corp III Life Sciences Warrant OACCW Stock Holding History

Shaolin Capital Management’s Portfolio OACCW Stock Details OACCW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$84.9K Sell
113,200
-1,800
-2% -$1.41K ﹤0.01% 346
2025
Q4 		$81.7K Hold
115,000
– – ﹤0.01% 337
2025
Q3 		$86.3K Hold
115,000
– – ﹤0.01% 260
2025
Q2 		$101K Hold
115,000
– – ﹤0.01% 203
2025
Q1 		$86.3K Sell
115,000
-19,000
-14% -$14.4K ﹤0.01% 117
2024
Q4 		$118K Buy
+134,000
New +$87.6K ﹤0.01% 118

Other funds holding OACCW

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $386M AUM 45.42% 1-Year Est. Return
BGIM
Boussard & Gavaudan Investment Management London, United Kingdom $1.06B AUM 4.58% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

Shaolin Capital Management's OACCW Position: Q1 2026 in Review

Shaolin Capital Management reduced its Oaktree Acquisition Corp III Life Sciences Warrant (OACCW) stake by 1.6% in Q1 2026, selling an estimated $1.41K and leaving 113,200 shares worth $84.9K. The position accounts for ﹤0.01% of the portfolio, ranked #346.

Shaolin Capital Management first reported a position in OACCW in Q4 2024 and has held it in 6 quarters since. The position peaked at $118K in Q4 2024. 26 funds tracked by Wall St. Rank hold OACCW as of Q1 2026.

  • Shaolin Capital Management held 113,200 shares of Oaktree Acquisition Corp III Life Sciences Warrant worth $84.9K as of Q1 2026.
  • Shaolin Capital Management sold 1,800 Oaktree Acquisition Corp III Life Sciences Warrant shares in Q1 2026, an estimated $1.41K.
  • Oaktree Acquisition Corp III Life Sciences Warrant made up ﹤0.01% of Shaolin Capital Management's portfolio in Q1 2026, its #346 holding.
  • Shaolin Capital Management first reported a position in Oaktree Acquisition Corp III Life Sciences Warrant in Q4 2024 and has held it in 6 quarters since.
  • Shaolin Capital Management's Oaktree Acquisition Corp III Life Sciences Warrant position peaked at $118K in Q4 2024.
  • 26 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences Warrant as of Q1 2026.

Based on Shaolin Capital Management's 13F filing for Q1 2026, filed 15 May 2026.